Skip to main content

Table 2 Demographic characterization of the cohort used in the preliminary validation

From: A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson’s disease potential biomarkers

  Age at blood coll. (y)a Genderb
Parkinson’s Disease Group 60.1 ± 10.7 [38, 79] M: 9 (40.9%); F: 13 (59.1%)
Control Group 67.5 ± 7.2 [53, 75] M: 3 (25%); F: 9 (75%)
  1. aAge at blood coll. (y): age at blood collection in years
  2. bThe individuals were divided into males (M) and females (F)